Randy Berholtz

Randy Berholtz, MBA/JD/M.Litt is the Chairman of the Board and the Chief Executive Officer of the Company. He has over 20 years of experience serving on the executive teams of biotech and pharmaceutical companies including Nanogen, Inc., (Nasdaq: NGEN), the ACON Group of private US and Chinese life science companies Apricus Biosciences, Inc. (Nasdaq: APRI), and Innovus Pharmaceuticals Inc (OTC: INNV). He is a Senior Advisor to Mesa Verde Venture Partners, LLC, a life sciences venture capital firm and he is on the board of directors of three private companies: Ambulero, Inc., Abbreos, Inc., and Eysz, Inc. He formerly worked with large law firms in New York and San Diego. He has a BA from Cornell, an M. Litt. from Oxford where he was a Rhodes Scholar, an MBA from the University of San Diego Business School, and a JD from Yale.